These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12715891)

  • 1. Structure-activity relationships of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Gelling R; Manhart S; Lynn F; Pederson RA; Kühn-Wache K; Rosche F; Demuth HU; Coy D; McIntosh CH
    Biol Chem; 2003 Mar; 384(3):403-7. PubMed ID: 12715891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
    Gault VA; Harriott P; Flatt PR; O'Harte FP
    Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
    Hinke SA; Manhart S; Pamir N; Demuth H; W Gelling R; Pederson RA; McIntosh CH
    Biochim Biophys Acta; 2001 May; 1547(1):143-55. PubMed ID: 11343800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide.
    Hinke SA; Manhart S; Speck M; Pederson RA; Demuth HU; McIntosh CH
    Life Sci; 2004 Aug; 75(15):1857-70. PubMed ID: 15302229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
    Green BD; Gault VA; Flatt PR; Harriott P; Greer B; O'Harte FP
    Arch Biochem Biophys; 2004 Aug; 428(2):136-43. PubMed ID: 15246869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Metabolism; 2003 Jun; 52(6):679-87. PubMed ID: 12800091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats.
    Hinke SA; Gelling RW; Pederson RA; Manhart S; Nian C; Demuth HU; McIntosh CH
    Diabetes; 2002 Mar; 51(3):652-61. PubMed ID: 11872663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
    Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
    Ehses JA; Lee SS; Pederson RA; McIntosh CH
    J Biol Chem; 2001 Jun; 276(26):23667-73. PubMed ID: 11323439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
    Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
    Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
    Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
    J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
    Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide.
    Gault VA; O'Harte FP; Harriott P; Flatt PR
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1420-6. PubMed ID: 11820780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide.
    Kerr BD; Flatt AJ; Flatt PR; Gault VA
    Biochem Biophys Res Commun; 2011 Jan; 404(3):870-6. PubMed ID: 21184739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational, receptor interaction and alanine scan studies of glucose-dependent insulinotropic polypeptide.
    Venneti KC; Malthouse JP; O'Harte FP; Hewage CM
    Biochim Biophys Acta; 2011 Jul; 1814(7):882-8. PubMed ID: 21539943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potential.
    Irwin N; O'Harte FP; Gault VA; Green BD; Greer B; Harriott P; Bailey CJ; Flatt PR
    J Med Chem; 2006 Feb; 49(3):1047-54. PubMed ID: 16451070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation, insulin secretion, and antihyperglycemic actions of two palmitate-derivitized N-terminal pyroglutamyl analogues of glucose-dependent insulinotropic polypeptide.
    Irwin N; Green BD; Gault VA; Greer B; Harriott P; Bailey CJ; Flatt PR; O'Harte FP
    J Med Chem; 2005 Feb; 48(4):1244-50. PubMed ID: 15715491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural requirements for gastric inhibitory polypeptide (GIP) receptor binding and stimulation of insulin release.
    Maletti M; Carlquist M; Portha B; Kergoat M; Mutt V; Rosselin G
    Peptides; 1986; 7 Suppl 1():75-8. PubMed ID: 3018705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GIP(3-30)NH
    Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
    Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
    Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
    Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.